Phospho-KIT (Tyr721) Antibody

What is c-Kit and why is phosphorylation at Tyr721 significant?

c-Kit (CD117) is a receptor tyrosine kinase that plays essential roles in cell survival, proliferation, hematopoiesis, stem cell maintenance, gametogenesis, mast cell development, and melanogenesis. The phosphorylation at Tyr721 is particularly significant because it creates a binding site for the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI3K), activating the PI3K-Akt signaling pathway . This specific phosphorylation site is homologous to Tyr723 in mouse and Tyr722 in rat c-Kit . When stem cell factor (SCF) binds to c-Kit, it triggers autophosphorylation at specific tyrosine residues including Tyr721, initiating downstream signaling cascades that regulate critical cellular processes .

What applications are suitable for Phospho-KIT (Tyr721) antibodies?

Phospho-KIT (Tyr721) antibodies can be utilized in multiple experimental applications:

• Western Blot (WB): For detecting denatured phosphorylated c-Kit protein in cell lysates

• Immunohistochemistry (IHC): For both paraffin-embedded (IHC-P) and frozen sections (IHC-F) of tissue samples

• Immunofluorescence (IF/ICC): For cellular localization studies

• Flow Cytometry (FCM): For quantifying phosphorylated c-Kit in cell populations

• ELISA: For quantitative determination of phosphorylated c-Kit levels

Most commercially available antibodies show reactivity with human, mouse, and rat samples, with predicted reactivity for other species including pig, bovine, horse, rabbit, dog, and chicken .

How should samples be prepared for optimal Phospho-KIT (Tyr721) detection?

For optimal detection of Phospho-KIT (Tyr721), samples should be prepared with careful attention to preserving phosphorylation status:

• Cell lysate preparation requires complete lysis buffer containing phosphatase inhibitors (both type I and II) and protease inhibitors to prevent dephosphorylation during sample processing

• For positive controls, cells should be stimulated with stem cell factor (SCF, 100 ng/mL for 2 minutes) before lysis

• Block plates with appropriate blocking solution (e.g., 150 μL of blocking solution for 1 hour with vigorous shaking at 300-1000 rpm)

• Wash plates thoroughly (three times with 300 μL/well of Tris Wash Buffer) before adding samples

• Sample dilution should be optimized depending on expression levels, with typical lysate concentrations ranging from 0.31-20 μg per well based on standard curves

How does subcellular localization affect c-Kit Tyr721 phosphorylation status?

The subcellular localization of c-Kit significantly impacts its phosphorylation status at Tyr721. Research has revealed that phosphorylation of c-Kit at different tyrosine residues occurs in distinct subcellular compartments:

• Full activation of c-Kit mutations (Kit(mut)) occurs only after the protein reaches the Golgi apparatus

• When Kit(mut) is retained in the endoplasmic reticulum (ER) using brefeldin A (BFA) treatment, phosphorylation at Tyr721 is partially reduced compared to other phosphorylation sites (Tyr568/570 and Tyr703) which are markedly dephosphorylated

• Even when Kit(mut) binds to PI3K in the ER, it cannot activate downstream Akt signaling, suggesting that proper subcellular localization is essential for functional signaling

• Immunostaining for phospho-tyrosine-721 shows strongest signal in the Golgi apparatus, confirming that maximal phosphorylation occurs in this organelle

• Swainsonine treatment, which inhibits α-mannosidase II at the medial-Golgi and alters protein glycosylation, does not affect Kit's activation of Akt, STAT5, and Erk, indicating that oncogenic Kit signaling on the Golgi is independent of glycosylation state

These findings demonstrate that phosphorylation at Tyr721 has specific subcellular regulation patterns that researchers must consider when designing experiments and interpreting results.

What methodological approaches can be used to quantify Phospho-KIT (Tyr721) levels?

Several methodological approaches can be employed to quantify Phospho-KIT (Tyr721) levels, each with distinct advantages:

• MSD® MULTI-ARRAY Assay System:

  • Provides quantitative measurement of phosphorylated c-Kit in cell lysates

  • Shows excellent signal-to-noise ratios (P/N ratio of 4.9-17) across a wide range of lysate concentrations (0.31-20 μg)

  • Enables simultaneous measurement of both phosphorylated and total c-Kit when using Phospho(Tyr721)/Total c-Kit assays

  • Typical data shows increased signal with positive cell lysate titration with %CV values generally below 8%

• Western Blot Analysis:

  • Traditional method for phospho-protein detection

  • Allows visualization of protein molecular weight (120kDa, 145kDa for c-Kit)

  • Can be used for comparative analysis but is less quantitative than specialized assays

• Immunohistochemical/Immunofluorescence Detection:

  • Enables spatial visualization of phosphorylated c-Kit in tissues and cells

  • Particularly useful for localizing phospho-signals to specific subcellular compartments

  • Can be combined with other markers to study pathway interactions

• 384-Well MULTI-ARRAY Phospho-c-Kit (Tyr721) Assay:

  • Optimized for high-throughput screening applications

  • Utilizes SULFO-TAG™ Anti-Phospho-c-kit antibodies for detection

  • Requires smaller sample volumes (10 μL/well)

The quantitative data table below compares lysate titration results for positive and negative M07e cell lysates:

How does Phospho-KIT (Tyr721) detection relate to oncogenic signaling pathways?

Phosphorylation of c-Kit at Tyr721 has significant implications for oncogenic signaling pathways, particularly in gastrointestinal stromal tumors (GISTs) and mastocytomas:

• Tyr721 phosphorylation is critical for association with the PI3K p85 subunit, which activates the PI3K-Akt pathway

• In GIST cells, oncogenic mutations in c-Kit lead to constitutive activation, with phosphorylation at Tyr721 playing a key role in dysregulated signaling

• The subcellular location of this phosphorylation is crucial - research demonstrates that Kit(mut) activates Akt signaling through PI3K specifically on the Golgi apparatus

• Co-immunoprecipitation experiments in GIST882 and GIST-R8 cells show that c-Kit associates with p85 even when retained in the ER, but this association fails to activate Akt signaling, highlighting the importance of proper cellular localization

• Other signaling pathways activated downstream of c-Kit phosphorylation include the Ras-Mek-Erk cascade and Src kinases, which regulate gene expression and cytoskeletal structures

Understanding the relationship between Tyr721 phosphorylation and these signaling pathways is essential for developing targeted therapies for c-Kit-driven malignancies.

What are the technical considerations for troubleshooting Phospho-KIT (Tyr721) antibody experiments?

When troubleshooting experiments using Phospho-KIT (Tyr721) antibodies, researchers should consider several technical factors:

• Phosphorylation Preservation:

  • Use freshly prepared lysis buffer with both protease and phosphatase inhibitors (type I and II)

  • Process samples quickly and maintain cold temperatures during preparation

  • Avoid multiple freeze-thaw cycles which can degrade phosphorylation signals

• Background Reduction:

  • Optimize blocking conditions (typically 1 hour with vigorous shaking at 300-1000 rpm)

  • Perform thorough washing steps (3 times with 300 μL/well of Tris Wash Buffer)

  • Use appropriate diluents for antibodies to minimize non-specific binding

• Signal Optimization:

  • Titrate antibody concentrations to determine optimal dilution (typically 1X final concentration)

  • Ensure positive controls (SCF-stimulated cells) show robust signal

  • Consider species-specific differences in phosphorylation sites (Tyr721 in human, Tyr723 in mouse, Tyr722 in rat)

• Result Verification:

  • Compare results with multiple detection methods (WB, ELISA, IF)

  • Validate findings with quantitative assays showing P/N ratios of at least 4.9 or higher

  • When analyzing data, expect %CV values below 8% for reliable quantification

• Subcellular Localization Considerations:

  • When studying c-Kit localization, remember that phosphorylation patterns differ between subcellular compartments

  • Use appropriate markers to confirm organelle identity in co-localization studies

How can Phospho-KIT (Tyr721) antibodies be used to study drug resistance mechanisms?

Phospho-KIT (Tyr721) antibodies are valuable tools for investigating drug resistance mechanisms in c-Kit-driven malignancies:

• Baseline phosphorylation levels can be assessed in patient samples or cell lines before treatment to predict response to tyrosine kinase inhibitors

• Monitoring changes in Tyr721 phosphorylation during treatment can identify early signs of resistance development

• Comparison of phosphorylation at different tyrosine residues (Tyr721, Tyr568/570, Tyr703) can reveal selective pressure on specific signaling pathways

• Subcellular localization studies can determine if drug resistance mechanisms involve altered trafficking of c-Kit between cellular compartments

• Quantitative assays can measure subtle changes in phosphorylation levels that may precede clinical resistance

A systematic approach using multiple detection methods and controls is recommended to comprehensively characterize resistance mechanisms.

What are the species-specific considerations when using Phospho-KIT (Tyr721) antibodies?

When working with Phospho-KIT antibodies across different species, researchers should consider several important factors:

• Phosphorylation Site Homology:

  • The Tyr721 phosphorylation site in human c-Kit corresponds to Tyr723 in mouse and Tyr722 in rat

  • Antibodies raised against the human sequence may have different affinities for mouse or rat proteins

• Reactivity Profiles:

  • Most commercial antibodies show confirmed reactivity with human, mouse, and rat samples

  • Predicted reactivity often extends to pig, bovine, horse, rabbit, dog, and chicken, but requires validation

• Molecular Weight Variations:

  • c-Kit appears at approximately 120kDa and 145kDa depending on glycosylation status

  • Species-specific differences in glycosylation patterns may affect apparent molecular weight

• Sequence Conservation:

  • The sequence surrounding the phosphorylation site is highly conserved across mammals but may contain subtle differences that affect antibody binding

  • Validation experiments should be performed when using the antibody in non-validated species

• Stimulus Response:

  • Species-specific differences in response to SCF stimulation may require optimization of stimulation protocols

  • The standard protocol (100 ng/mL SCF for 2 minutes) may need adjustment for non-human cell lines